ANTIPLATELET TREATMENT FOR THROMBOPROPHYLAXIS - A STEP FORWARD OR BACKWARDS

被引：42

作者：

COHEN, AT ^{[1
]}

SKINNER, JA ^{[1
]}

KAKKAR, VV ^{[1
]}

机构：

[1] THROMBOSIS RES INST,LONDON SW3 6LR,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1994年 / 309卷 / 6963期

关键词：

D O I：

10.1136/bmj.309.6963.1213

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A recent meta-analysis from the Antiplatelet Trialists' Collaboration recommended that antilatelet treatment either alone or, for greater effect, in addition to other proved forms of thromboprophylaxis should be considered for patients at high risk of thromboembolism. This paper argues that the current evidence does not justify the adoption of aspirin or other antiplatelet treatment for venous thromboprophylaxis, especially when more effective alternatives exist. Furthermore, several issues relating to this latest meta-analysis need to be debated.

引用

页码：1213 / 1215

页数：3

共 20 条

[1]

[Anonymous], 1994, BMJ, V308, P235

[2] PREVENTION OF VENOUS THROMBOEMBOLISM BY ADMINISTRATION OF HYDROXYCHLOROQUINE - PRELIMINARY-REPORT [J].